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Background 
• 178,000 women diagnosed with breast 
cancer in US in 2007 
• 62% localized to breast (stage T1, T2) 
• Treatment options include: 
– Mastectomy 
– Partial mastectomy with whole breast 
irradiation  
– Partial mastectomy with brachytherapy 
50% choose mastectomy 
www.print.duncans.tv/images/mastectomy-bus-sh 
50% choose partial mastectomy 
with whole breast irradiation 
www.breastdoc.com/.../BB-P143.jpg  
www.roswellpark.org/.../photos/  
Whole Breast Irradiation 
 
• 5-7 weeks of daily treatments 
• Disease-free survival is significantly 
improved with completion of therapy 





• Tumor bed most common site of 
recurrence 
• Led to efforts to target therapy to surgical 
site 
– Limit radiation side effects? 





• Placement of balloon catheter before 
treatment with radioactive seed placement 
twice daily for 5 days.  








• Initial studies- survival and cosmetic 
outcomes comparable to whole breast 
irradiation.  
• Identification of variables affecting 
outcomes other than tumor size, cell type 
and grade has been limited 
 
Literature Review 
• Most studies published in medical journals 
– Focused on disease recurrence rates, 
complication rates, and MD-judged cosmesis 
• No nursing studies 
 
Research Questions 
• For women selecting breast brachytherapy 
– What are most frequent complications? 
– What are the relationships of subject 
characteristics to treatment outcomes? 
– What are the relationships of tumor 
characteristics to treatment outcomes? 
– What are the relationships of treatment 




• Retrospective case series study  
• Medical records of subjects presenting for 
breast brachytherapy within the first year 





– N= 65, all Caucasian 
– Age 44-83 years, mean age- 62  
– BMI 20-49, mean 29.45 
– Breast size- 70% A, B, or C; 30% ≥ D  
– Post-menopausal  58 (90%) 
– HTN 32 (50%) 
– OA 21 (32%) 
– DM  13 (20% 
 
Tumor Characteristics 
• 92% T1, 8% T2 
• 75% IDC 
• Grade 
– 46% 1 
– 26% 2 
– 26% 3 
• 75% ER/PR+ 
• Quadrant  
– 52% UOQ 
– 19% UIQ 
– 13% LOQ 
– 10% LIQ 
– 6% Subareolar 
Therapy-related Characteristics 
• Margins 
– 58% ≤ 2mm 




– 61% endocrine 
– 21% anthracycline 
– 23 % other 
• Surgery to catheter placement  
– Range 0-60 days 
– Mean/median 21.7/21 days 
• Catheter in place (days) 
– Range 6-13  
– Mean/median 8.6/9 
Results 
• Disease recurrence 
– None at F/U (12-18 months) 
• Cosmesis 
– Excellent/Good 47/56 (84%) 
• As noted by MD 
– Not documented for 9 subjects 
– Few records included patient perception 
Results: Complications              
 
Complication N % 
Infection 7 10.8 
Chronic Pain 8 12.3 
Seroma 18 27.7 
Rad. Recall 5 7.7 
Fibrosis 6 9.2 
Results: Personal 
Characteristics and Outcome 
* p<.05, ** p<.01 
Chronic pain Fibrosis Infection Cosmesis 






Results: Tumor Characteristics 
and Outcome 
 * p<.05, ** p<.01 





Characteristics and Outcomes 
 * p<.05, ** p<.01 






















• Outcomes of recurrence, cosmesis, seroma and 
infection similar rates as previously published studies. 
• Re-resection was associated with seroma, chronic pain, 
and poorer cosmetic outcome. 
• Younger age and re-resection were associated with 
fibrosis. 
• Axillary node dissection was associated with infection, 
fibrosis and pain. 
• Initial data suggests good to excellent cosmetic 
outcomes and disease control. 
Conclusions (cont.) 
 
• Women with radiation recall reactions may be at 
greater risk for infection and seroma. 
• Older women were more likely to report pain and 
drainage from catheter site after therapy. 
• Recall reactions occurred in 5 of 14 subjects 
receiving anthracycline therapy. 
• Menopausal status was negatively associated 
with erythema and fibrosis. 
Limitations 
 
• Incomplete documentation of cosmetic 
and complications in medical records 
made outcome evaluation incomplete. 
• Small sample size. 
• Number of variables to consider in 
analysis large for data set size.  
• Patient satisfaction documented in only 






• Prospective study with standard data collection 
tool. 
• Follow this cohort for long-term outcomes. 
• Comparative analysis of outcomes with other 
therapies. 
• Sexuality effects of treatment 
• Qualitative studies- 
– Decision-making re: treatment options. 







• Minimize catheter time 
• Prophylactic Abx 
• Anthracycline Rx?- more aggressive 
prophylaxis & monitoring  
• Promote early detection 
• Ensure education re: treatment options 

